BRCA1 and breast cancer: TNBC also shares clinical and pathologic features with hereditary BRCA1-related breast cancers including lack of ER/PR and HER2neu, presence of p53 mutation, basal gene expression patterns, and BRCA1 inactivation by either mutation or pathway dysfunction [4–6].